Cite
Comorbidities and polypharmacy impact on complete cytogenetic response in chronic myeloid leukaemia elderly patients
MLA
Manuela Zappa, et al. “Comorbidities and Polypharmacy Impact on Complete Cytogenetic Response in Chronic Myeloid Leukaemia Elderly Patients.” European Journal of Internal Medicine, vol. 25, no. 1, Aug. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0e2a6f7e54674736da79cb7322744119&authtype=sso&custid=ns315887.
APA
Manuela Zappa, Cristina Bucelli, Daniele Cattaneo, Tommaso Radice, Agostino Cortelezzi, Daniela Mari, Silvia Artuso, Alessandra Iurlo, & Anna Ubertis. (2013). Comorbidities and polypharmacy impact on complete cytogenetic response in chronic myeloid leukaemia elderly patients. European Journal of Internal Medicine, 25(1).
Chicago
Manuela Zappa, Cristina Bucelli, Daniele Cattaneo, Tommaso Radice, Agostino Cortelezzi, Daniela Mari, Silvia Artuso, Alessandra Iurlo, and Anna Ubertis. 2013. “Comorbidities and Polypharmacy Impact on Complete Cytogenetic Response in Chronic Myeloid Leukaemia Elderly Patients.” European Journal of Internal Medicine 25 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0e2a6f7e54674736da79cb7322744119&authtype=sso&custid=ns315887.